Jun 18, 2019 4:37:00 PM
On 06/17/19 [10:29], RumorHound platform alerted a potential takeover of TherapeuticsMD (NasdaqGSM: TXMD; 2.61). Rumor is substantiated by 8 sources; 1 of which has a four-star reliability score, 3 with three-star scores, and an average source popularity ~2.0 (see image below). TXMD is a commercial-stage women’s healthcare company that offers a bio-identical hormone platform to treat menopause-related hormone deficiencies. The platform contains estradiol and progesterone alone or in combination and are designed to provide equivalent efficacy to competing products at lower doses, thus enabling enhanced safety and side effect profiles relative to custom compounded products.